Barinthus Biotherapeutics (BRNS)
1.05
0.08 (8.25%)
At close: Jan 15, 2025, 11:37 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 142.09M | 194.38M | 214.05M | 43.27M | 11.43M |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | -8.93M | -4.00M | n/a | n/a |
| Other Long-Term Assets | 882.00K | 976.00K | 804.00K | n/a | n/a |
| Receivables | 7.94M | 12.21M | 7.10M | 3.23M | 3.91M |
| Inventory | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 6.88M | 6.45M | 5.61M | 1.07M | 909.22K |
| Total Current Assets | 156.91M | 213.04M | 226.76M | 47.90M | 16.25M |
| Property-Plant & Equipment | 19.40M | 15.71M | 9.09M | 2.77M | 2.79M |
| Goodwill & Intangibles | 37.32M | 40.48M | 44.06M | n/a | n/a |
| Total Long-Term Assets | 57.60M | 57.16M | 53.95M | 2.77M | 2.79M |
| Total Assets | 214.51M | 270.20M | 280.71M | 50.67M | 19.04M |
| Account Payables | 1.60M | 3.75M | 2.42M | 4.67M | 3.89M |
| Deferred Revenue | n/a | 0.00 | 182.00K | 245.00K | 269.91K |
| Short-Term Debt | 1.78M | 433.00K | 682.00K | 192.00K | 171.98K |
| Other Current Liabilities | 9.21M | 8.06M | 7.88M | 2.54M | 1.42M |
| Total Current Liabilities | 12.60M | 12.24M | 11.16M | 7.64M | 5.75M |
| Long-Term Debt | 11.19M | 8.34M | 6.54M | 46.17M | 1.61M |
| Other Long-Term Liabilities | 3.15M | 2.68M | 2.37M | 33.77M | 33.76M |
| Total Long-Term Liabilities | 14.91M | 14.76M | 17.00M | 79.94M | 35.37M |
| Total Liabilities | 27.51M | 27.00M | 28.15M | 87.58M | 41.12M |
| Total Debt | 12.98M | 8.77M | 7.22M | 46.36M | 1.78M |
| Common Stock | 1K | 1K | 1K | 359.00 | 330.00 |
| Retained Earnings | -176.59M | -103.24M | -108.58M | -57.72M | -37.89M |
| Comprehensive Income | -23.32M | -33.46M | -8.49M | -1.24M | -467.36K |
| Shareholders Equity | 186.78M | 242.90M | 252.13M | -37.30M | -22.45M |
| Total Investments | -11.18M | -8.93M | -4.00M | n/a | n/a |